Ligand validation:1RZZ

U10: UBIQUINONE-10

U10 is a Ligand Of Interest in 1RZZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1RZZ_U10_M_1008	13%	14%	0.301	0.918	1.98	1.92	11	11	3	0	60%	0.6032
1RZZ_U10_S_2008	11%	13%	0.338	0.943	1.98	1.96	10	10	1	0	51%	0.5079
1RZZ_U10_L_1009	2%	6%	0.336	0.656	2.09	2.96	17	16	3	0	70%	0.6984
1RZZ_U10_R_2009	1%	8%	0.415	0.644	2.26	2.29	7	7	0	0	29%	0.2857
2BOZ_U10_M_1313	59%	20%	0.119	0.945	1.92	1.46	4	10	2	0	76%	0.7619
3ZUM_U10_M_1308	59%	8%	0.116	0.939	2.76	1.89	13	13	0	0	76%	0.7619
3ZUW_U10_M_1313	58%	9%	0.115	0.937	2.69	1.87	12	13	1	0	76%	0.7619
2GNU_U10_M_1305	55%	9%	0.111	0.931	2.57	1.9	11	16	1	0	71%	0.7143
2UWU_U10_M_1313	53%	11%	0.118	0.921	2.62	1.62	11	11	0	0	76%	0.7619
4NV5_U10_B_501	74%	26%	0.074	0.99	1.64	1.37	2	8	4	0	52%	0.5238

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.